The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors.
作者信息
Chan J Y, Burrowes C E, Habal F M, Movat H Z
出版信息
Biochem Biophys Res Commun. 1977 Jan 10;74(1):150-8. doi: 10.1016/0006-291x(77)91387-0.
PMID:65173
Abstract
摘要
相似文献
1
The inhibition of activated factor XII (Hageman factor) by antithrombin III: the effect of other plasma proteinase inhibitors.抗凝血酶III对活化因子XII（哈格曼因子）的抑制作用：其他血浆蛋白酶抑制剂的影响。
Biochem Biophys Res Commun. 1977 Jan 10;74(1):150-8. doi: 10.1016/0006-291x(77)91387-0.
2
Major inhibitors of the contact phase coagulation factors.接触相凝血因子的主要抑制剂。
Semin Thromb Hemost. 1987 Jan;13(1):69-78. doi: 10.1055/s-2007-1003476.
3
The biochemistry and pathophysiology of the contact system of plasma.血浆接触系统的生物化学与病理生理学
Adv Immunol. 1982;33:241-306. doi: 10.1016/s0065-2776(08)60837-8.
4
5
Plasma coagulation proteases, proteolytic inhibitors, and their interaction with platelets.血浆凝血蛋白酶、蛋白水解抑制剂及其与血小板的相互作用。
Pathobiol Annu. 1982;12:35-64.
6
The contribution of plasma protease inhibitors to antiplasmin activity in man.血浆蛋白酶抑制剂对人体抗纤溶酶活性的作用。
Clin Sci Mol Med. 1976 Aug;51(2):215-8. doi: 10.1042/cs0510215.
7
Protection by recombinant alpha 1-antitrypsin Ala357 Arg358 against arterial hypotension induced by factor XII fragment.重组α1-抗胰蛋白酶Ala357 Arg358对因子XII片段诱导的动脉低血压的保护作用。
J Clin Invest. 1987 Aug;80(2):582-5. doi: 10.1172/JCI113108.
8
The role of antithrombin III, alpha 2 macroglobulin and alpha 1 antitrypsin in progressive antithrombin activity of human plasma.抗凝血酶III、α2巨球蛋白和α1抗胰蛋白酶在人血浆抗凝血活性进展中的作用。
Int J Biochem. 1980;12(3):479-84. doi: 10.1016/0020-711x(80)90132-9.
9
引用本文的文献
1
Heat-Inactivation of Human Serum Destroys C1 Inhibitor, Pro-motes Immune Complex Formation, and Improves Human T Cell Function.热灭活人血清破坏 C1 抑制剂，促进免疫复合物形成，并改善人 T 细胞功能。
Int J Mol Sci. 2021 Mar 5;22(5):2646. doi: 10.3390/ijms22052646.
2
Potentiation of C1 esterase inhibitor by StcE, a metalloprotease secreted by Escherichia coli O157:H7.大肠杆菌O157:H7分泌的金属蛋白酶StcE对C1酯酶抑制剂的增强作用。
J Exp Med. 2004 Apr 19;199(8):1077-87. doi: 10.1084/jem.20030255.
3
C1-inhibitor substitution therapy in septic shock and in the vascular leak syndrome induced by high doses of interleukin-2.C1抑制剂替代疗法用于脓毒性休克和高剂量白细胞介素-2诱导的血管渗漏综合征。
Intensive Care Med. 1993;19 Suppl 1:S19-28. doi: 10.1007/BF01738946.
4
Enhancing effect of heparin on aprotinin activity.肝素对抑肽酶活性的增强作用。
Experientia. 1981 Nov 15;37(11):1179-81. doi: 10.1007/BF01989906.
5
Surface activation of factor XII (Hageman factor)--critical role of high molecular weight kininogen and another potentiator).因子 XII（哈格曼因子）的表面激活——高分子量激肽原和另一种增强剂的关键作用。
Agents Actions. 1978 Jan;8(1-2):65-72. doi: 10.1007/BF01972404.
Zotero 插件